Who
Ronald E. Blaylock
Director
Company insider
Files Form 4 as: Director, Pfizer; Director, W.R. Berkley; Director, CarMax; Director, Advantage Solutions; Director, Urban One.
In numbers
- Trades disclosed
- 135
- Buys
- 6
- Sells
- 12
- Bought
- $3.4M
- Sold
- $4.4M
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 17 May 2005
- Last trade
- 5 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Aug 2026filed 5 Aug 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Bought | $999K39,231 at $25.46 | filing |
| 5 Aug 2026filed 5 Aug 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Bought | $999K39,231 at $25.46 | filing |
| 3 Jun 2026filed 4 Jun 2026 | WRB W.R. BerkleyInsurance | SEC FORM 4 Code A | —3,090 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | WRB W.R. BerkleyInsurance | SEC FORM 4 Code A | —3,090 at $0.00 | filing |
| 23 Apr 2026filed 27 Apr 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K7,686.539 at $26.67 | filing |
| 23 Apr 2026filed 27 Apr 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K7,686.54 at $26.67 | filing |
| 11 Jun 2025filed 13 Jun 2025 | WRB W.R. BerkleyInsurance | SEC FORM 4 Code A | —2,776 at $0.00 | filing |
| 24 Apr 2025filed 28 Apr 2025 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K8,999 at $22.78 | filing |
| 13 Feb 2025filed 14 Feb 2025 | PFE PfizerPharmaceuticals | SEC FORM 4 Bought | $499K19,457 at $25.65 | filing |
| 1 Jul 2024filed 2 Jul 2024 | KMX CarMaxAuto Parts & Dealers | SEC FORM 4 Code A | —2,598 at $0.00 | filing |
| 12 Jun 2024filed 12 Jun 2024 | WRB W.R. BerkleyInsurance | SEC FORM 4 Code A | —2,534 at $0.00 | filing |
| 25 Apr 2024filed 26 Apr 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K8,115.6 at $25.26 | filing |
| 30 Jun 2023filed 5 Jul 2023 | KMX CarMaxAuto Parts & Dealers | SEC FORM 4 Code A | —2,210 at $0.00 | filing |
| 14 Jun 2023filed 14 Jun 2023 | WRB W.R. BerkleyInsurance | SEC FORM 4 Code A | —3,479 at $0.00 | filing |
| 27 Apr 2023filed 28 Apr 2023 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K5,291.69 at $38.74 | filing |
| 1 Jul 2022filed 5 Jul 2022 | KMX CarMaxAuto Parts & Dealers | SEC FORM 4 Code A | —1,996 at $0.00 | filing |
| 15 Jun 2022filed 15 Jun 2022 | WRB W.R. BerkleyInsurance | SEC FORM 4 Code A | —2,995 at $0.00 | filing |
| 25 May 2022filed 27 May 2022 | ADV Advantage SolutionsBusiness Services | SEC FORM 4 Code A | —40,603 at $0.00 | filing |
| 28 Apr 2022filed 29 Apr 2022 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K4,058.6 at $50.51 | filing |
| 16 Jul 2021filed 20 Jul 2021 | KMX CarMaxAuto Parts & Dealers | SEC FORM 4 Sold | $1.7M12,500 at $132.02 | filing |
News
Pfizer's Stock Is Finally Showing Signs of Life. Could This Be the Start of a Much Bigger Rally?PFE · fool.com · 19 Oct 2026Critical Analysis: Nexentis Technologies (NASDAQ:NXTS) versus Pfizer (NYSE:PFE)PFE · dailypolitical.com · 19 Oct 2026Bristol Myers is Cheaper Than Pfizer, but Its 40% Earnings Jump Has a CatchPFE · insidermonkey.com · 19 Oct 2026
0 headlines in the last 90 days name Ronald E. Blaylock; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.